Emmaus Life Sciences Announces Opening of Office in New York to Support Endari LaunchMarch 26, 2018 Read More
Emmaus Life Sciences Receives Validation From European Medicines Agency on Marketing Authorization Application for Sickle Cell Disease Treatment Xyndari (oral glutamine)March 12, 2018 Read More
Emmaus Life Sciences Announces Medicaid Coverage of Endari™ (L-glutamine oral powder) for Sickle Cell Disease in the United StatesJanuary 29, 2018 Read More
Emmaus Life Sciences Announces Availability of Endari™ (L-glutamine oral powder) for Sickle Cell Disease in the United StatesJanuary 18, 2018 Read More
